Share of Clicks for top 10 US Pharma & Biotech Pulmonology brands
Here are the Top 10 competitors in the industry by Share of Clicks for the last month.
| Domain | Share of clicks |
|---|---|
| dupixenthcp.com | 18.59 |
| yupelrihcp.com | 17.41 |
| breztri.com | 9.55 |
| tezspire.com | 7.36 |
| fasenra.com | 5.51 |
| tezspirehcp.com | 5.13 |
| breztrihcp.com | 3.94 |
| dupixent.com | 3.82 |
| primatene.com | 2.75 |
| yupelri.com | 2.65 |
| others | 23.29 |
- dupixenthcp.com - 18.59%
- yupelrihcp.com - 17.41%
- breztri.com - 9.55%
- tezspire.com - 7.36%
- fasenra.com - 5.51%
- tezspirehcp.com - 5.13%
- breztrihcp.com - 3.94%
- dupixent.com - 3.82%
- primatene.com - 2.75%
- yupelri.com - 2.65%
- others - 23.29%
Copyright © Adthena. All rights reserved.
In the PPC landscape, dupixenthcp.com leads with 18.59% click share, closely followed by yupelrihcp.com at 17.41%. Others collectively hold 23.29%, showcasing diverse competition.
Share of Spend for the top 10 US Pharma & Biotech Pulmonology brands
Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month.
| Date | dupixenthcp.com | tezspire.com | gsk.com | tezspirehcp.com | dupixent.com | nucala.com | breztri.com | yupelrihcp.com | fasenra.com | breztrihcp.com |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025/12/01 | 12.15% | 10.85% | 1.12% | 6.68% | 0.37% | 0.04% | 18.95% | 8.82% | 2.11% | 9.23% |
| 2025/12/02 | 14.78% | 6.29% | 2.78% | 0.68% | 2.45% | 4.76% | 32.12% | 11.37% | 1.82% | 2.31% |
| 2025/12/03 | 9.16% | 9.24% | 1.42% | 1.7% | 3.77% | 1.34% | 19.44% | 8.33% | 0.4% | 8.99% |
| 2025/12/04 | 18.69% | 6.36% | 2.12% | 5.22% | 4.83% | 6.95% | 18.84% | 10.63% | 6.09% | 4.38% |
| 2025/12/05 | 17.27% | 6.78% | 1.6% | 5.82% | 7.24% | 2.3% | 12.73% | 7.18% | 4.06% | 5.23% |
| 2025/12/06 | 16.55% | 4.5% | 1.57% | 3.86% | 6.65% | 0.95% | 16.18% | 8.46% | 3.16% | 8.82% |
| 2025/12/07 | 19.99% | 2.55% | 3.85% | 1.86% | 17.54% | 2.35% | 16.69% | 11.11% | 0.25% | 4.66% |
| 2025/12/08 | 7.95% | 3.54% | 3.18% | 3.29% | 6.97% | 12.1% | 15.98% | 13.7% | 8.39% | 3.66% |
| 2025/12/09 | 10.14% | 16.98% | 2.32% | 10.73% | 1.47% | 1.69% | 10.18% | 5.11% | 2.66% | 4.02% |
| 2025/12/10 | 23.44% | 3.34% | 4.98% | 1.01% | 0.19% | 0.45% | 6.56% | 20.02% | 5.77% | 2.21% |
| 2025/12/11 | 12.91% | 3.28% | 5.24% | 1.3% | 1.35% | 1.38% | 10.59% | 18.37% | 6.85% | 6.3% |
| 2025/12/12 | 29.78% | 4.71% | 7.26% | 2.8% | 1.74% | 3.29% | 11.44% | 14.63% | 4.39% | 3.1% |
| 2025/12/13 | 9.1% | 4.57% | 0.85% | 1.4% | 0.39% | 0.17% | 27.2% | 20.11% | 19.13% | 2.13% |
| 2025/12/14 | 13.72% | 6.25% | 3.27% | 6.11% | 6.31% | 2.99% | 6.93% | 13.44% | 9.66% | 1.42% |
| 2025/12/15 | 19.96% | 2.91% | 3.31% | 3.44% | 0.22% | 4.19% | 10.76% | 20.16% | 10.13% | 3.35% |
| 2025/12/16 | 19.08% | 8.06% | 2.48% | 3.7% | 2.97% | 4.03% | 15.05% | 12.82% | 4.36% | 3.98% |
| 2025/12/17 | 21.98% | 6.32% | 2.62% | 6.76% | 2.28% | 1.48% | 4.55% | 14.33% | 10.31% | 1.53% |
| 2025/12/18 | 25.47% | 7.44% | 2.36% | 6.14% | 1.55% | 0.23% | 5.8% | 23.03% | 4.25% | 2.51% |
| 2025/12/19 | 14.77% | 7.51% | 2.06% | 6.03% | 5.78% | 0.23% | 12.2% | 2.55% | 19.77% | 10.03% |
| 2025/12/20 | 26.07% | 15.19% | 2.87% | 14.33% | 3.03% | 0.14% | 5.66% | 2.3% | 10.37% | 3.17% |
| 2025/12/21 | 33.48% | 1.88% | 2.95% | 1.41% | 5.2% | 3.24% | 11.13% | 2.12% | 3.54% | 8.72% |
| 2025/12/22 | 19.15% | 7.58% | 2.01% | 11.16% | 3.35% | 1.32% | 3.32% | 16.94% | 10.12% | 2.25% |
| 2025/12/23 | 22.82% | 1.56% | 2.52% | 1.17% | 2.96% | 0.51% | 6.85% | 31.49% | 6.12% | 4.88% |
| 2025/12/24 | 11.01% | 1.9% | 2.43% | 0.3% | 7.91% | 16.38% | 9.4% | 21.41% | 11.48% | 3.32% |
| 2025/12/25 | 13.3% | 18.53% | 3.04% | 10.6% | 2.4% | 0.26% | 6.26% | 18.18% | 5.55% | 3.64% |
| 2025/12/26 | 17.44% | 2.71% | 3.34% | 0.78% | 1.11% | 0.57% | 8.11% | 28.48% | 11.52% | 6.03% |
| 2025/12/27 | 16.49% | 6.74% | 3.21% | 2.48% | 6.2% | 1.85% | 4.84% | 26.16% | 3.61% | 2.47% |
| 2025/12/28 | 18.48% | 10.44% | 2.25% | 8.64% | 1.59% | 0.63% | 7.71% | 12.77% | 3.96% | 6.93% |
| 2025/12/29 | 7.08% | 7.16% | 3.39% | 7.25% | 6.18% | 3.41% | 7.55% | 11.29% | 2.53% | 20.52% |
| 2025/12/30 | 26.48% | 13.19% | 4.13% | 9.19% | 1.05% | 1.28% | 5% | 3.58% | 3.98% | 5.51% |
| 2025/12/31 | 22.74% | 20.66% | 3.86% | 3.64% | 3.38% | 3.26% | 2.29% | 2.28% | 2.2% | 1.2% |
- dupixenthcp.com
- tezspire.com
- gsk.com
- tezspirehcp.com
- dupixent.com
- nucala.com
- breztri.com
- yupelrihcp.com
- fasenra.com
- breztrihcp.com
Copyright © Adthena. All rights reserved.
In December 2025, dupixenthcp.com saw fluctuating PPC spend, peaking at 33.48 on the 21st. Meanwhile, tezspire.com ended strong with 20.66 on the 31st. Breztri.com started high but declined, finishing at 2.29.
Competitor Count for US Pharma & Biotech Pulmonology
Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month.
| Date | Competitor Count |
|---|---|
| 2025/12/01 | 41 |
| 2025/12/02 | 39 |
| 2025/12/03 | 39 |
| 2025/12/04 | 43 |
| 2025/12/05 | 50 |
| 2025/12/06 | 47 |
| 2025/12/07 | 41 |
| 2025/12/08 | 41 |
| 2025/12/09 | 43 |
| 2025/12/10 | 43 |
| 2025/12/11 | 39 |
| 2025/12/12 | 40 |
| 2025/12/13 | 39 |
| 2025/12/14 | 39 |
| 2025/12/15 | 40 |
| 2025/12/16 | 39 |
| 2025/12/17 | 36 |
| 2025/12/18 | 32 |
| 2025/12/19 | 34 |
| 2025/12/20 | 35 |
| 2025/12/21 | 32 |
| 2025/12/22 | 32 |
| 2025/12/23 | 36 |
| 2025/12/24 | 39 |
| 2025/12/25 | 39 |
| 2025/12/26 | 37 |
| 2025/12/27 | 40 |
| 2025/12/28 | 42 |
| 2025/12/29 | 41 |
| 2025/12/30 | 41 |
| 2025/12/31 | 42 |
Copyright © Adthena. All rights reserved.
December began with 41 advertisers, peaking at 50 on the 5th. A decline followed, reaching 32 by the 18th. The month concluded with a slight recovery, ending at 42 advertisers.
